glp-1 benefits for weight loss of Semaglutide GLP-1 medications | Milliman |
Description
Announced in June 2025, the CNPV program aims to expedite the review of drugs that address unmet medical needs, improve affordability, or support public health priorities
References Abrahami D, DAndrea E, Yin H, Kim SC, Paik JM, Wexler D, et al
doi: 10.1002/edm2.70038
These results suggest that the analgesic effects of exendin 939 via TRPV1 are similar to those of BCTC
Indeed, most patients discontinue the use of these drugs within one year, and nausea and related GI side effects are often cited as the reason
